Hetrombopag Olamine ( DrugBank: Hetrombopag )

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
60	再生不良性貧血	3
63	特発性血小板減少性紫斑病	2

60. 再生不良性貧血

臨床試験数 : 245 / 薬物数 : 318 - (DrugBank : 86) / 標的遺伝子数 : 44 - 標的パスウェイ数 : 166

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05088642 (ClinicalTrials.gov)	September 28, 2020	12/10/2021	A Trial of Hetrombopag in Healthy and Hepatic Impairment Subjects	A Phase I Clinical Study Evaluating the Pharmacokinetics and Safety of Hetrombopag OlamineTablets in ...	Sever Aplastic Anaemia	Drug: Hetrombopag Olamine Tablet	Jiangsu HengRui Medicine Co., Ltd.	NULL	Completed	18 Years	65 Years	All	24	Phase 1	China
2	NCT05088174 (ClinicalTrials.gov)	September 3, 2020	12/10/2021	A Trial of Hetrombopag in Healthy Subjects	A Single-Center, Single-Arm, Open-Label, Self-Controlled, Drug-Drug Interaction Study of Hetrombopag ...	Sever Aplastic Anaemia	Drug: Hetrombopag Olamine Tablet;Ciclosporin Soft Capsule	Jiangsu HengRui Medicine Co., Ltd.	NULL	Completed	18 Years	65 Years	All	26	Phase 1	China
3	NCT04961710 (ClinicalTrials.gov)	September 19, 2019	12/7/2021	Extension Study of Hetrombopag in Severe Aplastic Anemia	Extension Study of Hetrombopag Olamine in Patients With Treatment-naive Severe Aplastic Anemia	Treatment-naive Severe Aplastic Anemia	Drug: Hetrombopag Olamine;Drug: Placebo	Jiangsu HengRui Medicine Co., Ltd.	NULL	Recruiting	15 Years	75 Years	All	180	Phase 3	China

臨床試験数 : 391 / 薬物数 : 235 - (DrugBank : 50) / 標的遺伝子数 : 49 - 標的パスウェイ数 : 139

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02614846 (ClinicalTrials.gov)	August 2015	19/11/2015	Safety and Efficacy Study of Hetrombopag Olaminein Chronic Idiopathic Thrombocytopenic Purpura (ITP) ...	A Safety, Pharmacokinetics and Pharmacodynamics Study of Hetrombopag Olaminein Chronic Idiopathic Th ...	Chronic Idiopathic Thrombocytopenic Purpura	Drug: Hetrombopag Olamine	Jiangsu HengRui Medicine Co., Ltd.	NULL	Recruiting	18 Years	65 Years	Both	29	Phase 1	China
2	NCT02403440 (ClinicalTrials.gov)	April 2014	20/3/2015	A Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients	A Safety, Pharmacokinetics and Pharmacodynamics Study of Hetrombopag Olaminein Chronic Idiopathic Th ...	Purpura, Thrombocytopenic, Idiopathic	Drug: Hetrombopag Olamine	Jiangsu HengRui Medicine Co., Ltd.	NULL	Recruiting	18 Years	65 Years	Both	24	Phase 1	China